These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2121388)

  • 1. Cardiac allograft function with corticosteroid-free maintenance immunosuppression.
    O'Connell JB; Bristow MR; Rasmussen LG; Ratkovec RM; Gay WA; Jones KW; Renlund DG
    Circulation; 1990 Nov; 82(5 Suppl):IV318-21. PubMed ID: 2121388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved long-term survival after heart transplantation predicted by successful early withdrawal from maintenance corticosteroid therapy.
    Taylor DO; Bristow MR; O'Connell JB; Price GD; Hammond EH; Doty DB; Karwande SV; Gay WA; Jones KW; Lappé D; Renlund DG
    J Heart Lung Transplant; 1996 Oct; 15(10):1039-46. PubMed ID: 8913922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective comparison of murine monoclonal CD-3 (OKT3) antibody-based and equine antithymocyte globulin-based rejection prophylaxis in cardiac transplantation. Decreased rejection and less corticosteroid use with OKT3.
    Renlund DG; O'Connell JB; Gilbert EM; Hammond ME; Burton NA; Jones KW; Karwande SV; Doty DB; Menlove RL; Herrick CM
    Transplantation; 1989 Apr; 47(4):599-605. PubMed ID: 2523099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular dysfunction after heart transplantation: incidence and role of enhanced immunosuppression.
    McNamara D; Di Salvo T; Mathier M; Keck S; Semigran M; Dec GW
    J Heart Lung Transplant; 1996 May; 15(5):506-15. PubMed ID: 8771506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of heart transplant recipients treated with murine antihuman mature T cell monoclonal antibody (OKT3): the Loyola experience.
    Costanzo-Nordin MR; O'Sullivan EJ; Hubbell EA; Zucker MJ; Pifarre R; McManus BM; Winters GL; Scanlon PJ; Robinson JA
    J Heart Transplant; 1989; 8(4):288-95. PubMed ID: 2504895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation.
    Bonaros N; Dunkler D; Kocher A; Imhof M; Grimm M; Zuckermann A; Wolner E; Laufer G
    J Heart Lung Transplant; 2006 Sep; 25(9):1154-63. PubMed ID: 16962480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis.
    Trouillot TE; Shrestha R; Kam I; Wachs M; Everson GT
    Liver Transpl Surg; 1999 Sep; 5(5):375-80. PubMed ID: 10477838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid-free maintenance immunotherapy: Minneapolis Heart Institute experience.
    Pritzker MR; Lake KD; Reutzel TJ; Hoffman FM; Jorgensen CR; Pederson W; Emery RW
    J Heart Lung Transplant; 1992; 11(2 Pt 2):415-20. PubMed ID: 1571339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased cardiac allograft rejection in female heart transplant recipients.
    Crandall BG; Renlund DG; O'Connell JB; Burton NA; Jones KW; Gay WA; Doty DB; Karwande SV; Lee HR; Holland C
    J Heart Transplant; 1988; 7(6):419-23. PubMed ID: 3062147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic OKT3 used as induction therapy for heart transplantation.
    Starnes VA; Oyer PE; Stinson EB; Dein JR; Shumway NE
    Circulation; 1989 Nov; 80(5 Pt 2):III79-83. PubMed ID: 2509108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of steroid withdrawal in pediatric renal allograft recipients (a 5-year follow-up).
    Roberti I; Reisman L; Lieberman KV; Burrows L
    Clin Transplant; 1994 Aug; 8(4):405-8. PubMed ID: 7949548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple-drug immunosuppression with steroid discontinuation by six months after heart transplantation.
    Olivari MT; Jessen ME; Baldwin BJ; Horn VP; Yancy CW; Ring WS; Rosenblatt RL
    J Heart Lung Transplant; 1995; 14(1 Pt 1):127-35. PubMed ID: 7727461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticosteroid-free maintenance immunosuppression after heart transplantation: feasibility and beneficial effects.
    Price GD; Olsen SL; Taylor DO; O'Connell JB; Bristow MR; Renlund DG
    J Heart Lung Transplant; 1992; 11(2 Pt 2):403-14. PubMed ID: 1571338
    [No Abstract]   [Full Text] [Related]  

  • 14. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.
    Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD
    J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating cardiac allograft rejection: present approach--analysis of 100 consecutive patients.
    Radovancevic B; Birovljev S; Frazier OH
    J Heart Transplant; 1990; 9(3 Pt 2):288-91. PubMed ID: 2113091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
    Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
    J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial success of steroid weaning late after heart transplantation.
    Kobashigawa JA; Stevenson LW; Brownfield ED; Moriguchi JD; Kawata N; Fandrich R; Drinkwater DC; Laks H
    J Heart Lung Transplant; 1992; 11(2 Pt 2):428-30. PubMed ID: 1571341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique antithymocyte serum versus OKT3 for induction immunotherapy after heart transplantation.
    Frist WH; Merrill WH; Eastburn TE; Atkinson JB; Stewart JR; Hammon JW; Bender JW
    J Heart Transplant; 1990; 9(5):489-94. PubMed ID: 2121921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with Muromonab-CD3 monoclonal antibody (OKT3) in heart transplantation.
    Macris MP; Frazier OH; Lammermeier D; Radovancevic B; Duncan JM
    J Heart Transplant; 1989; 8(4):281-7. PubMed ID: 2504894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful reversal of acute cardiac allograft rejection with OKT*3 monoclonal antibody.
    Costanzo-Nordin MR; Silver MA; O'Connell JB; Pifarre R; Grady KL; Winters GL; Murdock DK; Sullivan HJ; Grieco JG; Scanlon PJ
    Circulation; 1987 Nov; 76(5 Pt 2):V71-80. PubMed ID: 3311459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.